Weight-loss, diabetes drugs linked to vision problems in small study
GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.
Patients on Ozempic report ‘waking up blind’ in as little as a day after using jab
PATIENTS taking blockbuster diabetes and weight loss drugs are waking up with vision loss, researchers warn. Some reported ...